MONDAY, May 6, 2024 (HealthDay News) — An injectable gene therapy caused measurable improvements in vision among a small group of people with inherited blindness, an early-stage clinical trial says. Researchers recruited 14 people with Leber Congenital Amaurosis (LCA), a rare genetic condition that causes babies to lose some orContinue Reading

FRIDAY, March 29, 2024 (HealthDay News) — Stem cells derived from a patient’s own fat can safely help improve sensation and movement after a spinal cord injury, a new, small study finds. Patients treated with these stem cells experienced increased sensation from pinpricks and light touches, increased muscle strength andContinue Reading

MONDAY, March 18, 2024 (HealthDay News) — Breathing and relaxation techniques may offer relief to some patients battling Long COVID. In a new, small study of 20 patients, biofeedback therapy relieved both the physical and psychological symptoms of Long COVID, researchers said. Many participants had been dealing with symptoms forContinue Reading

MONDAY, Feb. 19, 2024 (HealthDay News) — When settling into your senior years, you need to be especially careful when taking medicines, herbal remedies and supplements, the U.S. Food and Drug Administration says. That’s because older adults are likely to use more prescription and over-the-counter medications, which increases the riskContinue Reading

WEDNESDAY, Feb. 14, 2024 (HealthDay News) — Acupuncture may protect people with rheumatoid arthritis (RA) from stroke, new research suggests. The study indicates that a course of acupuncture treatment may lower blood levels of inflammatory proteins called cytokines that are linked to heart disease, the No. 1 cause of deathContinue Reading

FRIDAY, Dec. 15, 2023 (HealthDay News) — Patients with advanced heart failure can benefit from stem cell therapy, a large, new clinical trial has found. Injections of stem cells programmed to heal damaged heart tissue wound up improving overall quality of life for heart failure patients, compared to those whoContinue Reading

FRIDAY, Dec. 8, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved two milestone gene therapies for sickle cell disease, including the first treatment ever approved that uses gene-editing technology. Casgevy, developed by Vertex Pharmaceuticals of Boston and CRISPR Therapeutics of Switzerland, is the first medicineContinue Reading